A simple model that suggests possible cost savings when modified-release prednisone 5 mg/day is added to current treatment in patients with active rheumatoid arthritis

M. Boers, F. Buttgereit

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1435-1437
JournalRheumatology
Volume52
Issue number8
DOIs
Publication statusPublished - 2013

Cite this

@article{16c3758ebab7446abae4383b334fbd2b,
title = "A simple model that suggests possible cost savings when modified-release prednisone 5 mg/day is added to current treatment in patients with active rheumatoid arthritis",
author = "M. Boers and F. Buttgereit",
year = "2013",
doi = "10.1093/rheumatology/ket145",
language = "Undefined/Unknown",
volume = "52",
pages = "1435--1437",
journal = "Rheumatology",
issn = "1462-0324",
publisher = "Oxford University Press",
number = "8",

}

A simple model that suggests possible cost savings when modified-release prednisone 5 mg/day is added to current treatment in patients with active rheumatoid arthritis. / Boers, M.; Buttgereit, F.

In: Rheumatology, Vol. 52, No. 8, 2013, p. 1435-1437.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - A simple model that suggests possible cost savings when modified-release prednisone 5 mg/day is added to current treatment in patients with active rheumatoid arthritis

AU - Boers, M.

AU - Buttgereit, F.

PY - 2013

Y1 - 2013

U2 - 10.1093/rheumatology/ket145

DO - 10.1093/rheumatology/ket145

M3 - Article

VL - 52

SP - 1435

EP - 1437

JO - Rheumatology

JF - Rheumatology

SN - 1462-0324

IS - 8

ER -